Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression changes in response to microparticle treatment in mouse macrophages

ABSTRACT: Gene expression changes in response to microparticle treatment in mouse macrophages

PROVIDER: PRJNA745192 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15089825_1.fastq.gz	Fastqsanger.gz
	SRR15089825_2.fastq.gz	Fastqsanger.gz
	SRR15089826_1.fastq.gz	Fastqsanger.gz
	SRR15089826_2.fastq.gz	Fastqsanger.gz
	SRR15089827_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Gene expression changes in response to microparticle treatment in mouse macrophages

Project description:To investigate the potential molecular mechanisms of the microparticles' ability to rescue TLR4-deficient mice under Gram-negative infection, we performed RNA-seq experiments in J774A.1 mouse macrophage cell lines, under MP, LPS, and LPS+MP treatments. As expected, ~2000 genes were induced in response to LPS, and the degree of upregulation is significantly higher than down-regulation. In the presence of MP, LPS still upregulated ~1800 genes, similar to LPS treatment alone, but there were significantly more downregulated genes, indicating that MP has profound effects under LPS challenge, primarily through down-regulation of gene expression. A total of 1267 DEGs were found in the MP-treatment group, including 631 upregulated genes and 636 downregulated genes. The average fold change is much smaller than LPS and LPS+MP groups. Functional category analyses of these MP-upregulated genes revealed significant enrichment of immune-related GO terms, including response to stress, toxic substances, and homeostatic process. The results suggest that the MP upregulated the expression of ~600 genes, fine-tuning the immune profile.

2024-07-09 | GSE179829 | GEO

FE1 lung epithelial cells: Control vs nanoparticle, microparticle, metal chloride exposed

Project description:Control vs nanoparticle, microparticle, metal chloride exposed

2024-01-18 | GSE246159 | GEO

MSCs-encapsulated porous microparticle eye drops for autoimmune dry eye disease treatment

Project description:MSCs-encapsulated porous microparticle eye drops for autoimmune dry eye disease treatment

| PRJNA1252463 | ENA

Single cell transcriptomic studies of an Antigen-Specific Dual Microparticle Treatment of a Mouse Model of Multiple Sclerosis

Project description:A microparticle system using GMCSF, TGF-b, and VD3 along with disease specific antigen (Myelin Oligodendrocyte Protein) shows effiacy in treating a mouse model of multiple sclerosis, while GMCSF, TGF-b, and VD3 and irrelevant OVA antigen did not reduce scores. Here we show that pro-inflammatory and cell cycle genes are downregulated in multiple populations. scRNA-seq further revealed a reduction in antigen-presentation gene signature.

2025-03-21 | GSE199073 | GEO

Advax, a delta inulin microparticle, potentiates in-built adjuvant property of co-administered vaccines

Project description:Gene expression data from mouse organs after Advax injection Advax, an inulin-derived microparticle, has been developed as an adjuvant for several vaccines. Advax is a unique class of adjuvant which can potentiate the endogenous adjuvant effect of the vaccines through a not yet fully-identified, unique mechanisms of action.

2017-01-31 | GSE89249 | GEO

Identification and Validation of microparticle proteins as biomarkers for diabetic retinopathy

Project description:Diabetic retinopathy (DR) is a microvascular complication that develops in diabetic individuals. There are currently no methods to detect the onset or progression of DR. Biomarkers can help identify the subset of diabetics who are at high risk of developing DR or those DR patients with a high probability to progress quickly to advanced stage. In this study, we examined the serum microparticles as a source of biomarkers for DR. We profiled the microparticle proteome and compared across six different sample groups representing the onset and progression of DR. We found that the microparticle proteins participate in DR pathogenesis. We also validated eight of these proteins and found two to be biomarkers for DR.

2025-01-17 | PXD036079 | Pride

Vitamin D treatment of M.tb. infected macrophages

Project description:As macrophages are the primary site of Mtb infection and are sites of vitamin D signaling, we have used these cells to understand the molecular mechanisms underlying modulation of the immune response by the hormonal form of vitamin D, 1,25-dihydroxyvitamin D (1,25D). Microarrays were used to measure the changes in gene expression induced by 1,25D treatment of H37Rv-infected THP-1 cells

2013-11-28 | GSE52819 | GEO

Vitamin D treatment of M.tb. infected macrophages

2013-11-28 | E-GEOD-52819 | biostudies-arrayexpress

Protein abundance changes in response to high light treatment

Project description:To characterize Arabidopsis proteomics and transcritomics changes in response to high light treatment. We quantify specific transcipts and protein abundance changes under both control and high light stress conditions. We aim to investigate the causality and interconnection of transcription and protein abundance change by an in-depth analysis of protein turnover, RNA-seq and 15N spike-in quantitative proteomics.

2022-07-12 | PXD010888 | Pride

Transcriptomic changes of HepG2 cell line in response to treatment with boric acid

Project description:Transcriptomic changes of HepG2 cell line in response to treatment with boric acid

| PRJNA596445 | ENA